Samuel H Davis

This inventor holds 71 USPTO granted patents and 28 published patent applications, plus 9 CIPO patents and 21 EPO patents, primarily in Immunotherapy Development (CPC class C07K). Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc., Other. Active years: 1978-2026.

USPTO Granted Patents = 71 (Patent Applications = 28)

% Patents Active = 80.3

CIPO Patents = 9 (Patent Applications = 13)

EPO Patents = 21 (Patent Applications = 37)

Average Co-Inventor Count = 3.2

ph-index = 22

Forward Citations = 1,547(Granted Patents)

Forward Citations (Not Self Cited) = 1,473(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Jericho, NY (US) (1978 - 1984)
New York, NY (US) (1993 - 2024)

Company Filing History:

66 out of 1,473

Regeneron Pharmaceuticals, Inc.

patents

1 out of 49

Regeneran Pharmaceuticals, Inc.

patents

4 out of 834,350

Other

patents

Years Active: 1978-2026

Loading Chart...

Areas of Expertise:

Immunotherapy

Bispecific Antibodies

IL-2 Variants

Chimeric Constant Domains

Tumor Treatment

VEGF Binding

Gene Modification

Receptor Agonists

Pharmacokinetic Properties

Cell Culture Compositions

71 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528851 - IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF (2026-01-20),

2. 12522638 - IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF (2026-01-13),

3. 12509516 - Heavy Chain Constant Regions with Reduced Binding to Fc Gamma Receptors (2025-12-30),

4. 12509514 - Antibodies Comprising Chimeric Constant Domains (2025-12-30),

5. 12391753 - Antigen binding molecule formats (2025-08-19),

6. 12331109 - Antigen binding molecule formats (2025-06-17),

7. 12215148 - Antigen binding molecule formats (2025-02-04),

8. 12180272 - Antigen binding molecule formats (2024-12-31),

9. 12168681 - Il-2 variants with reduced binding to IL-2 receptor alpha and uses thereof (2024-12-17),

10. 12157758 - Readily isolated bispecific antibodies with native immunoglobulin format (2024-12-03),

11. 12090193 - Glucagon-like peptide 1 receptor agonists and uses thereof (2024-09-17),

12. 11965020 - Antigen binding molecule formats (2024-04-23),

13. 11834485 - IL-2 variants with reduced binding to IL-2 receptor alpha and uses thereof (2023-12-05),

14. 11779633 - Glucagon-like peptide 1 receptor agonists and uses thereof (2023-10-10),

15. 11708407 - Antigen binding molecule formats (2023-07-25),

Title: The Inventor Samuel H Davis: Pioneering Innovations in Jericho, NY

Introduction: Samuel H Davis is a distinguished inventor based in Jericho, NY, known for his groundbreaking contributions to various industries.

Latest Patents: Samuel H Davis holds several patents in the fields of technology, healthcare, and consumer products, showcasing his versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Samuel H Davis has consistently pushed the boundaries of innovation, with his inventions revolutionizing the way we live and work.

Collaborations: Throughout his career, Samuel H Davis has collaborated with leading companies, research institutions, and universities to bring his ideas to life, demonstrating his ability to work across disciplines and sectors.

Conclusion: Samuel H Davis stands as a visionary inventor whose passion for innovation continues to inspire the next generation of inventors and creators.